Double Unit Cord Blood Transplantation (dCBT) Progression-Free Survival (PFS) is Unaffected by Grade III-IV Acute Graft-Versus-Host Disease (aGVHD) and Survivors Are Likely to Discontinue Immunosuppression (IS) and Reconstitute T-Cells
Year: 2016
Type: article
Abstract: While dCBT is effective therapy for hematologic malignancies it can be complicated by GVHD. However, how acute & chronic GVHD (aGVHD/ cGVHD) impact PFS, the likelihood patients (pts) will discontinue IS & the kinetics of T-cell recovery by GVHD severity are not established.
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2341317553